Results 101 to 110 of about 30,645 (194)
Abstract Supplement HIV Glasgow 8–11 November 2026, Glasgow, UK/Virtual
Journal of the International AIDS Society, Volume 29, Issue S6, November 2026.
wiley +1 more source
[[abstract]]Earlier studies addressing the hepatitis B virus (HBV) DNA cut-off level for inactive chronic HBV infection largely involved patients with normal alanine aminotransferase (ALT) for only 1–2 years and based on a single time HBV DNA assay. This
Chen, YC;Huang, SF;Chu, CM;Liaw, YF
core +1 more source
Using machine learning models to predict HBeAg seroconversion in CHB patients receiving pegylated interferon-α monotherapy. [PDF]
Shang H +12 more
europepmc +1 more source
The underlying mechanisms for earlier hepatitis B e antigen (HBeAg) seroconversion in patients with chronic hepatitis B virus (HBV) genotype B when compared with genotype C are unknown.
Wong, BCY +13 more
core +1 more source
The decline of HBV RNA associated with HBeAg seroconversion and double-negative HBV DNA and RNA in chronic hepatitis B patients who received entecavir therapy: a 10-year retrospective cohort study. [PDF]
Ye F +12 more
europepmc +1 more source
The pathologic role of hepatitis B virus (HBV) genotype in Chinese patients with HBV infection is largely unknown. We examined the relationship between HBV genotypes, and hepatitis B e antigen (HBeAg) seroconversion, acute exacerbation, cirrhosis-related
Wong, BCY +7 more
core +1 more source
Comparison of the efficacies between LAM+ADV and LdT+ADV treatment in ALT normalization rate and DNA undetectable rate and serum HBeAg seroconversion rate.
Yi-Hao Yen (837269) +6 more
core +1 more source
Aim: to assess the safety and efficacy of telbivudine therapy in adult patients with CHB in Indonesia. Methods: the study design was prospective cohort study.
Ali Sulaiman +3 more
doaj +4 more sources
Background and aimsCurrent guidelines are controversial regarding the continuation of nucleos(t)ide analogues (NAs) therapy after delivery in Hepatitis B virus (HBV)-infected pregnant women.
Wenting Zhong +6 more
doaj +1 more source

